David H Sherr

9PUBLICATIONS
32CO-AUTHORS
Molecular targetsEnvironmental biogeochemistryAutoimmunityNanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 12, 2025
The aryl hydrocarbon receptor controls IFN-γ-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma.

Megan Snyder, Zhongyan Wang, Brian Lara

|Aug 26, 2024
The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma.

Megan Snyder, Zhongyan Wang, Brian Lara

|Mar 29, 2023
The Ah Receptor from Toxicity to Therapeutics: Report from the 5th AHR Meeting at Penn State University, USA, June 2022.

Gary H Perdew, Charlotte Esser, Megan Snyder

|May 04, 2021
The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation.

Jessica E Kenison, Zhongyan Wang, Kangkang Yang

|Jan 05, 2021
How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Zhongyan Wang, Megan Snyder, Jessica E Kenison

|Nov 26, 2020
Tolerogenic nanoparticles suppress central nervous system inflammation.

Jessica E Kenison, Aditi Jhaveri, Zhaorong Li

Pageof 2